A Study to Compare Meloxicam IM Once Daily Versus Meloxicam Orally Once Daily in Patients With Rheumatoid Arthritis
Status:
Completed
Trial end date:
2004-12-31
Target enrollment:
Participant gender:
Summary
The objective of this trial was to assess the efficacy and safety of 15 mg meloxicam i.m.
once daily compared with 15 mg meloxicam tablets once daily p.o. in patients with Rheumatoid
arthritis over a time period of 7 days.